Control Group:Modified BUCY
Sponsors
Aerospace Center Hospital
Conditions
Relapse and Refractory Acute Myelocytic Leukemia
Phase 4
Comparison of the curative efficacy and safety of allo-HSCT by using conditioning regiment of modified BUCY or CLAG combined with modified BUCY for refractory and relapsed patients with acute myelocytic leukemia: a sigle-center prospective randomized controlled clinical trial
Active, not recruitingChiCTR-IPR-16009917
Start: 2017-01-01Updated: 2017-04-18
A multicenter, open, prospective controlled clinical study comparing the efficacy and safety of CLAG regimen combined with modified BUCY and modified BUCY regimen in allogeneic hematopoietic stem cell transplantation in the treatment of relapsed and refractory AML
Active, not recruitingChiCTR2100049606
Start: 2021-08-31Updated: 2022-04-19